You have 9 free searches left this month | for more free features.

Withdrawal

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

E-cigarette Use, Withdrawal Trial in Baltimore (Transdermal Nicotine Patch, Placebo Nicotine Patch)

Not yet recruiting
  • E-cigarette Use
  • Withdrawal
  • Transdermal Nicotine Patch
  • Placebo Nicotine Patch
  • Baltimore, Maryland
    Behavioral Pharmacology Research Unit
Sep 28, 2023

Opiate Withdrawal Syndrome, Opioid Use Trial in Philadelphia (LFX/PGB, LFX/PLA-PGB)

Not yet recruiting
  • Opiate Withdrawal Syndrome
  • Opioid Use
  • Philadelphia, Pennsylvania
    University of Pennsylvania, Treatment Research Center
Aug 18, 2023

Immune Tolerance, Immunosuppression, Liver Transplant; Complications Trial in Tianjin (Tacrolimus or Cyclosporine A)

Not yet recruiting
  • Immune Tolerance
  • +2 more
  • Tacrolimus or Cyclosporine A
  • Tianjin, Tianjin, China
    Tianjin First Central Hospital
Nov 23, 2023

Opioid Withdrawal (Disorder) Trial (Standard of Care with Lofexidine, Standard of Care without Lofexidine)

Not yet recruiting
  • Opioid Withdrawal (Disorder)
  • Standard of Care with Lofexidine
  • Standard of Care without Lofexidine
  • (no location specified)
Sep 14, 2023

Heart Failure, Electric Impedance, Dyspnea Trial in Córdoba (Diuretics withdrawal, Diuretics maintenance)

Recruiting
  • Heart Failure
  • +4 more
  • Diuretics withdrawal
  • Diuretics maintenance
  • Córdoba, Córdoba (Andalucía), Spain
    Hospital Universitario Reina Sofía
Jul 25, 2023

Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome Trial in Hershey (microRNA-146a level, microRNA-192 level,

Recruiting
  • Neonatal Opioid Withdrawal Syndrome
  • Neonatal Abstinence Syndrome
  • microRNA-146a level
  • +2 more
  • Hershey, Pennsylvania
    Penn State Milton S. Hershey Medical Center
Jun 30, 2023

Withdrawal of Colchicine in Behçet Syndrome

Not yet recruiting
  • Behçet's Syndrome
  • (no location specified)
Nov 17, 2023

Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)

Not yet recruiting
  • Opioid Use Disorder
  • Opioid Withdrawal
  • BXCL501 (180 micrograms)
  • +3 more
  • (no location specified)
Jan 24, 2023

Chronic Insomnia, Hypnotic Dependence Trial in Lausanne (Medium duration withdrawal programme with ACT, Long duration withdrawal

Active, not recruiting
  • Chronic Insomnia
  • Hypnotic Dependence
  • Medium duration withdrawal programme with ACT
  • +3 more
  • Lausanne, Switzerland
    PROSOM
Oct 13, 2022

Effective Withdrawal Time and Adenoma Detection Rate

Not yet recruiting
  • Colonic Polyp
  • +2 more
  • Endoscreen QC
  • (no location specified)
Sep 30, 2023

Sarcoidosis Trial (STOP arm)

Not yet recruiting
  • Sarcoidosis
  • STOP arm
  • (no location specified)
Jan 16, 2023

Using Clonidine and/or Buprenorphine

Recruiting
  • Withdrawal Syndrome
  • Clonidine, Buprenorphine
  • Surrey, British Columbia, Canada
    Salem Anaesthesia Pain Clinic
May 28, 2023

Opioid Use Disorder Trial (sphenopalatine ganglion block)

Not yet recruiting
  • Opioid Use Disorder
  • sphenopalatine ganglion block
  • (no location specified)
Jan 3, 2023

Neonatal Abstinence Syndrome Trial in Charleston (Spark Biomedical Roo Transcutaneous Auricular Neurostimulation (tAN) System)

Completed
  • Neonatal Abstinence Syndrome
  • Spark Biomedical Roo Transcutaneous Auricular Neurostimulation (tAN) System
  • Charleston, South Carolina
    Medical University of South Carolina
Dec 7, 2022

Withdrawal; Therapeutic Substance Trial in Houston (Clonidine (without protocolized initiation), Clonidine (protocolized

Recruiting
  • Withdrawal; Therapeutic Substance
  • Clonidine (without protocolized initiation)
  • Clonidine (protocolized initiation)
  • Houston, Texas
    Children's Memorial Hermann Hospital
Jan 24, 2023

Alcohol Withdrawal Trial in Copenhagen (Blood samples)

Recruiting
  • Alcohol Withdrawal
  • Blood samples
  • Copenhagen, Denmark
    Bispebjerg and Frederiksberg Hospital
Sep 28, 2022

Methamphetamine Use Disorder Trial in Richmond (Oxytocin nasal spray)

Not yet recruiting
  • Methamphetamine Use Disorder
  • Oxytocin nasal spray
  • Richmond, Victoria, Australia
    Turning Point
Mar 6, 2023

Opioid Use Disorder, Opioid Withdrawal, Opioid Craving Trial in Baltimore (Buspirone, Lofexidine, Placebo)

Not yet recruiting
  • Opioid Use Disorder
  • +3 more
  • Baltimore, Maryland
    Behavioral Pharmacology Research Unit
Aug 19, 2022

Methadone vs. Transdermal Fentanyl for Opioid Withdrawal

Not yet recruiting
  • Delirium in the Intensive Care Unit
  • Administration of methadone instead of fentanyl patch
  • Kfar Saba, Israel
    Meir medical center Kfar Saba
Jan 15, 2023

Opioid Use Disorder Trial in Wernersville (Bridge™ active device, Bridge™ sham device)

Enrolling by invitation
  • Opioid Use Disorder
  • Bridge™ active device
  • Bridge™ sham device
  • Wernersville, Pennsylvania
    Caron Treatment Centers
Jun 21, 2023

Glucocorticoid Withdrawal Syndrome in Treated Cushing Syndrome

Recruiting
  • Cushing Syndrome
  • MUSE biofeedback
  • Rochester, Minnesota
    Mayo Clinic
Oct 31, 2022

Heart Failure With Reduced Ejection Fraction, Heart Rhythm Disorder Trial (GDMT)

Not yet recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Heart Rhythm Disorder
  • (no location specified)
Nov 9, 2023

Kratom Product Effects Among Regular Consumers

Not yet recruiting
  • Withdrawal Symptoms
  • Effects from acute kratom exposure
  • (no location specified)
Oct 20, 2023

Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Withdrawal;Drug
  • Imatinib withdrawal
  • +2 more
  • Brno, Czechia
  • +7 more
Aug 24, 2022

T-bet B Cells in Persistent Virus Control After Discontinuance

Completed
  • Chronic HBV Infection
  • Drug Withdrawal
  • T-bet B cell
  • Shanghai, China
    Changhai hospital
Sep 1, 2023